Induction of mitosis in T-lymphocytes

Induction of mitosis in T-lymphocytes is a complex biological process characterized by the activation, growth, and clonal expansion of T-cells in response to specific or non-specific stimuli (Davidson's Principles and Practice of Medicine). This phenomenon, often referred to as T-cell activation or blastogenesis, involves the transition of quiescent lymphocytes from the G0 phase into the active cell cycle (PubMed, PMID: 10508291). The process is primarily mediated by the T-cell receptor (TCR) complex upon recognition of antigens presented by major histocompatibility complex (MHC) molecules, or by mitogenic agents such as phytohaemagglutinin (PHA) that bypass specific antigen requirements (ChEMBL, CHEMBL614415). Successful induction leads to the upregulation of activation markers like CD25 and the secretion of cytokines, particularly interleukin-2 (IL-2), which drives further proliferation (StatPearls, NBK537314). In clinical pharmacology, this process is a critical focal point; it is suppressed by drugs like cyclosporine and tacrolimus to prevent transplant rejection and autoimmune activity, while its stimulation is a goal in vaccine development and certain cancer immunotherapies (NIH, PubChem). Because it represents a multi-component cellular event rather than a single molecule, it is classified as a phenotypic target in pharmacological research.

Other names

T-cell activationT-cell proliferationLymphocyte transformationBlastogenesisMitogenesis in T-cells

Stimulation of the T-cell receptor (TCR) complex or bypass of TCR signaling by mitogens, leading to the activation of calcineurin, NFAT, and MAPK pathways, which induces IL-2 production and cell cycle progression from G0 to S phase (PubMed, PMID: 10508291).